In conclusion, the results provide strong molecular evidence to support the view that, both in vitro and in vivo, hesperetin enhances the anti-tumor effects induced by DDP on GC cells by activating the mitochondrial pathway and negatively regulating the PI3K/AKT signaling pathway by upregulating PTEN expression. The gene discussed is AKT1; the disease is gastric cancer.